Loading...
OTCM
IRME
Market cap3mUSD
Jul 11, Last price  
0.05USD
1D
0.00%
Jan 2017
4,700.00%
IPO
-100.00%
Name

IR-MED Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
19.61%
Rev. gr., 5y
%
Revenues
0k
Net income
0k
P
-900-248,000-761,000-3,721,000-9,462,000-4,909,0000
CFO
-1m
L-57.12%
-72,000-402,000-2,482,000-3,375,000-3,232,000-1,386,000

Profile

IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
IPO date
Jul 18, 2001
Employees
7
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
1,941
4,928
4,637
Unusual Expense (Income)
NOPBT
(1,941)
(4,928)
(4,637)
NOPBT Margin
Operating Taxes
4,728
Tax Rate
NOPAT
(1,941)
(4,928)
(9,365)
Net income
(4,909)
-48.12%
(9,462)
154.29%
Dividends
Dividend yield
Proceeds from repurchase of equity
755
1,000
3,625
BB yield
-2.28%
-10.73%
Debt
Debt current
157
39
236
Long-term debt
200
154
Deferred revenue
Other long-term liabilities
35
Net debt
28
(528)
(2,612)
Cash flow
Cash from operating activities
(1,386)
(3,232)
(3,375)
CAPEX
(2)
(50)
Cash from investing activities
(2)
(59)
Cash from financing activities
750
1,000
3,625
FCF
(1,653)
(4,842)
(9,560)
Balance
Cash
129
767
3,002
Long term investments
Excess cash
129
767
3,002
Stockholders' equity
(14,770)
(9,862)
Invested Capital
(137)
15,335
12,765
ROIC
ROCE
1,416.79%
EV
Common stock shares outstanding
70,759
69,404
67,578
Price
0.47
 
0.50
-77.27%
Market cap
33,082
 
33,789
-75.66%
EV
33,110
31,177
EBITDA
(1,920)
(4,911)
(4,627)
EV/EBITDA
Interest
6
Interest/NOPBT